ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2523

Region, Race, and Hospital Factors Impact Length of Stay and Hospital Charges Post-primary Total Knee Arthroplasty

Kranti Rumalla1, Sumanth Chandrupatla2 and Jasvinder Singh2, 1Northwestern School of Medicine, Chicago, IL, 2University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2023

Keywords: Arthroplasty, Health Services Research, Outcome measures, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: Osteoarthritis (OA) affects nearly 33 million adults in the US and total knee arthroplasty (TKA) is an effective treatment. Outcomes can vary by regional and hospital level disparities. We sought to determine patient characteristics and hospital level factors of extended hospital stays and increased costs in patients with knee OA who underwent primary TKA in a nationally representative sample.

Methods: We examined patients from the 2019 National Inpatient Sample (NIS) with OA who underwent primary TKA using the International Classification of Disease 10th Edition (ICD-10) Diagnosis and Procedure codes. Patient and regional characteristics were assessed. Primary outcomes were extended length of stay (eLOS) and increased hospital charges (IHC), determined as the upper quartile of each outcome. Multivariable analysis determined independent predictors for each outcome. Area Under the Curve (AUC) analysis assessed classification ability.

Results: 543,291 patients underwent TKA in 2019; 61.7% were female and 81.3% were white. Independent predictors of IHC include hospital bed size (p < 0.001), location & teaching status (p < 0.001), and hospital control (p < 0.001). South and West region hospitals a significantly higher adjusted odds ratio (aOR 1.54 & 2.79, p < 0.001) of IHC when compared to Northeastern region hospitals. Significant independent predictors of eLOS include race & ethnicity (p < 0.001), payer (p < 0.001), and hospital control (p < 0.001). Multivariable models for eLOS and IHC had AUC C-statistic scores of 0.74 and 0.76, respectively, demonstrating a modest classification ability.

Conclusion: Patient race/ethnicity, payer, regional and hospital level characteristics impacted outcomes and costs for the OA patients who underwent primary TKA in 2019. A stronger emphasis to address regional, hospital-level, and racial disparities can improve outcomes for the thousands of OA patients who undergo TKA every year.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: K. Rumalla: None; S. Chandrupatla: None; J. Singh: Other, 2, 6, 11, 11, 12, Adaptimmune Therapeutics, GeoVax Labs, Pieris Pharmaceuticals, Enzolytics Inc., Seres Therapeutics, Tonix, Charlotte’s Web, 12, Atai life sciences, kintara therapeutics, Intelligent Biosolutions, Acumen pharmaceutical, TPT Global Tech, Vaxart pharmaceuticals, Atyu biopharma, 12, speaker’s bureau of Simply Speaking, other, 12, received institutional research support from Zimmer Biomet Holdings. JAS received food and beverage payments from Intuitive Surgical Inc./Philips Elec, Other, 12, Schipher, Crealta/Horizon, Medisys, Fidia, PK Med, Two labs Inc., Adept Field Solutions, Clinical Care options, Clearview healthcare partners, Putnam.

To cite this abstract in AMA style:

Rumalla K, Chandrupatla S, Singh J. Region, Race, and Hospital Factors Impact Length of Stay and Hospital Charges Post-primary Total Knee Arthroplasty [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/region-race-and-hospital-factors-impact-length-of-stay-and-hospital-charges-post-primary-total-knee-arthroplasty/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/region-race-and-hospital-factors-impact-length-of-stay-and-hospital-charges-post-primary-total-knee-arthroplasty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology